-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Initiates Coverage On Bicara Therapeutics with Buy Rating, Announces Price Target of $28

Benzinga·01/08/2026 13:18:50
语音播报
BTIG analyst Jeet Mukherjee initiates coverage on Bicara Therapeutics (NASDAQ:BCAX) with a Buy rating and announces Price Target of $28.